# A letter to the Croton Planning Board opposing approval of a cannabis dispensary in the village. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/community-opposition-medical-cannabis-access/ > **Published:** 2026-04-07T21:03:34-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:27:59-04:00 > **Clinical Summary:** Explore community opposition medical cannabis and its impact on patient access to regulated dispensaries and treatments in local areas. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic [Patient Access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/)PolicyCommunity Opposition[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Regulatory Why This Matters Local opposition to cannabis dispensaries often reflects persistent stigma and misinformation that can impact [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) to regulated medical cannabis. Understanding community concerns helps clinicians anticipate barriers their patients may face in accessing recommended treatments. Clinical Summary This represents typical community resistance to cannabis retail establishments, commonly based on unfounded safety concerns rather than evidence-based [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) data. Studies consistently show that regulated dispensaries do not increase crime rates or youth access compared to prohibition models. The opposition likely stems from decades of prohibition-era messaging rather than clinical or epidemiological evidence. Dr. Caplan’s Take “I see this pattern repeatedly — communities rejecting dispensaries based on fear rather than facts. My patients deserve access to regulated, tested products without having to drive hours or resort to unregulated markets.” Clinical Perspective 🧠 Clinicians should be prepared to educate patients about potential access challenges in their communities and discuss alternative legal options. This type of local opposition underscores why physician education and community engagement remain essential for advancing evidence-based cannabis policy. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20A%20letter%20to%20the%20Croton%20Planning%20Board%20opposing%20approval%20of%20a%20cannabis%20dispensary...%20%40drcaplan&url=https%3A//thecrotonchronicle.substack.com/p/a-letter-to-the-croton-planning-board%3Futm_source%3Dsubstack%26utm_medium%3Demail%26utm_content%3Dshare%26action%3Dshare)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//thecrotonchronicle.substack.com/p/a-letter-to-the-croton-planning-board%3Futm_source%3Dsubstack%26utm_medium%3Demail%26utm_content%3Dshare%26action%3Dshare)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20A%20letter%20to%20the%20Croton%20Planning%20Board%20opposing%20approval%20of%20a%20cannabis%20dispensary...%20--%20via%20%40drcaplan.bsky.social%20https%3A//thecrotonchronicle.substack.com/p/a-letter-to-the-croton-planning-board%3Futm_source%3Dsubstack%26utm_medium%3Demail%26utm_content%3Dshare%26action%3Dshare)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://thecrotonchronicle.substack.com/p/a-letter-to-the-croton-planning-board?utm_source=substack&utm_medium=email&utm_content=share&action=share](https://thecrotonchronicle.substack.com/p/a-letter-to-the-croton-planning-board?utm_source=substack&utm_medium=email&utm_content=share&action=share) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [What type of cannabis-related content does this article cover?](#What_type_of_cannabis-related_content_does_this_article_cover) - [Why is this article marked as “New”?](#Why_is_this_article_marked_as_8220New8221) - [What does “Notable Clinical Interest” mean for healthcare providers?](#What_does_8220Notable_Clinical_Interest8221_mean_for_healthcare_providers) - [How does community opposition relate to medical cannabis access?](#How_does_community_opposition_relate_to_medical_cannabis_access) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating signifies emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What type of cannabis-related content does this article cover? This is a cannabis news article from CED Clinic that focuses on multiple aspects including patient access, policy developments, and medical cannabis. The content appears to address community opposition issues as well. #### Why is this article marked as “New”? The “New” designation indicates this is recently published or updated content. This helps readers identify the most current information and emerging developments in cannabis policy and clinical practice. #### What does “Notable Clinical Interest” mean for healthcare providers? Articles with “Notable Clinical Interest” rating contain emerging findings or policy developments that could impact clinical practice. Healthcare providers should monitor these developments as they may influence [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions or treatment protocols. #### How does community opposition relate to medical cannabis access? Community opposition can significantly impact patient access to medical cannabis by influencing local policies and dispensary locations. This creates barriers for patients who may benefit from medical cannabis treatments, making it an important clinical consideration. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [A letter to the Croton-on-Hudson Planning Board opposing approval of a cannabis …](https://cedclinic.com/local-cannabis-dispensary-zoning-impact/) Read another community letter opposing cannabis dispensary approval, highlighting local concerns and regulatory challenges. [Read More](https://cedclinic.com/local-cannabis-dispensary-zoning-impact/) [Questions for the attorney representing the applicant for a cannabis dispensary in Croton.](https://cedclinic.com/local-cannabis-dispensary-licensing-questions-attorney-croton/) Explore legal perspectives and key questions surrounding cannabis dispensary applications in Croton. [Learn More](https://cedclinic.com/local-cannabis-dispensary-licensing-questions-attorney-croton/) [Retail cannabis applicants vent after ruling stalls an already 'slow as molasses' license rollout](https://cedclinic.com/cannabis-retail-licensing-delays-stall-patient-access/) Understand the frustrations of cannabis retail applicants facing delays in licensing and regulatory hurdles. [Discover More](https://cedclinic.com/cannabis-retail-licensing-delays-stall-patient-access/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).